Akums Drugs & Pharmaceuticals, operating in the Pharmaceuticals sector and classified as a Smallcap on the BSE, currently has its share price at ₹434.15. The stock has experienced fluctuations ...

Akums Drugs share price crashed almost 7 per cent in intraday trade on the BSE on Wednesday, 22 January, after the company said the Income Tax Department conducted a search at its offices and ...

Know all about Akums that won 'Game Changers in Disease Diagnosis' award at the 5th Healthcare heroes Awards.

Akums Drugs has signed an agreement with a global pharma player to supply formulations to European market, which the company says will help 'opens doors' to further expand in the market. Post ...

(Image Credits: Pixabay) Akums Drugs & Pharmaceuticals Ltd. on Tuesday announced the launch of a pioneering Ripasudil-Timolol combination therapy for glaucoma treatment. Glaucoma ranks as the ...

Involves transaction of at least 0.5% of the listed shares of a company. Akums Drugs & Pharmaceuticals Ltd share price was up by 2.81% from the previous closing price of ₹460.25. Who are peers ...

is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period. Earnings Per Share (TTM ...

The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.

The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.